Medpace Holdings, Inc. Financial Statements FY2024-FY2026Q3

Medpace Holdings, Inc. (MEDP) Financial Statements in Beancount — Open Ledger

Medpace's income statement and balance sheet, FY2024 through FY2026Q3, as a public, auditable plain-text Beancount ledger — reconstructed line by line from the company's own Form 10-K and 10-Q filings and version-controlled in git. Part of the Open Ledger project on beancount.io.

Browse it live: beancount.io/ledger/open_ledger/medpace

Latest analysis: Medpace Q3 2026 Earnings: The $716M Quarter That Ran on Client Cash

Key Figures

Amounts in MUSD (millions of US dollars), exactly as the ledger records them.

What's Inside

Fiscal years end December 31; fiscal quarters end on the calendar quarter (Q3 September 30). All figures sourced from Medpace Holdings, Inc. Form 10-K and Form 10-Q filings (SEC EDGAR, CIK 0001668397). Medpace is a clinical contract research organization (CRO): upfront client fees sit in advanced billings (modeled as deferred revenue), and years of buybacks retired enough stock to leave an accumulated deficit beside positive equity. History starts at FY2024 — the two most recent audited annuals plus the current quarter.

Quick Start

uvx --from beancount bean-check main.bean
uvx --from beanquery bean-query main.bean \
  "SELECT year, sum(position) WHERE account ~ '^Income:Revenue' GROUP BY year ORDER BY year"

Zero output from bean-check means the ledger is internally consistent: every
income statement sums to zero and every balance-sheet snapshot reconciles to
the filed totals. The query prints revenue by calendar year; income is a
credit, so it shows as a negative number. Open main.bean in Fava
or import it into beancount.io to explore it visually.

Methodology

• Balance sheet — pad / balance directives assert each period-end
  figure against the filing named in that period file's source banner.
• Income statement — one zero-sum transaction per period: Income
  negative (credit), Expenses positive (debit), with the arithmetic check in
  a comment directly above it.
• Unit — MUSD; 716 MUSD means 716 million US dollars.
• Additional accounts — Assets:NonCurrent:OperatingLeaseRightOfUse
  with Liabilities:Current:OperatingLeases (the current portion, disclosed
  in the lease note inside other current liabilities) and
  Liabilities:NonCurrent:OperatingLeases for the ASC 842 lease balances,
  and Equity:TreasuryStock for shares held at cost (a debit balance).
• Company specifics — advanced billings ride
  Liabilities:Current:DeferredRevenue; total direct costs are two labeled
  postings on Expenses:CostOfRevenue (direct service costs plus reimbursed
  out-of-pocket expenses); the filing's own depreciation and amortization
  lines ride Expenses:OtherNet. The statements carry no noncontrolling
  interest, so net income as filed is fully attributable.

Analysis

• Medpace Q3 2026 Earnings: The $716M Quarter That Ran on Client Cash — FY2026Q3

Corrections

Found a figure that does not match the filing? Email
[email protected] with the period, the account
and the filing page. Corrections are committed with the source cited.

About Open Ledger

Open Ledger is a growing library of public-company financial statements
published as plain-text accounting at
beancount.io/ledger — git-versioned, diffable
across companies, and auditable against primary filings. Read the analysis
behind the numbers on the beancount.io blog.

Disclaimer

This ledger is an independent reconstruction of Medpace Holdings, Inc.'s publicly filed
financial statements, provided for educational and informational purposes
only. It is not investment, financial, legal, tax, or accounting advice, and
is not an offer or recommendation to buy or sell any security. Beancount.io is
not affiliated with, endorsed by, or sponsored by Medpace Holdings, Inc.; all trademarks
belong to their respective owners. Figures may contain errors, omissions, or
simplifications and may lag the latest filings — the company's own regulatory
filings are the authoritative source. Provided "as is" without warranty of any
kind; use at your own risk.